Search research articles
Contact Us
Filters
Showing results (1-10 of 34) with videos related to
Page
of 4
Sort By:
World Journal of Gastroenterology
|
October 12, 2011
Combined inhibitors of angiogenesis and histone deacetylase: efficacy in rat hepatoma
Marion Ganslmayer, Annette Zimmermann, Steffen Zopf, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 14, 2025
Sevoflurane-induced periostitis
Christian Beyer, Bernhard Manger, Marion Ganslmayer, et al.
Studies in Health Technology and Informatics
|
May 20, 2008
A randomized controlled trial to evaluate an electronic scoring tool in the ICU
Thomas Bürkle, Alexander Beisig, Marion Ganslmayer, et al.
Scandinavian Journal of Gastroenterology
|
January 2, 2009
Peginterferon alfa-2a relapse rates depend on weight-based ribavirin dosage in HCV-infected patients with genotype 1: results of a retrospective evaluation
Steffen Zopf, Christoph Herold, Eckhart G Hahn, et al.
European Journal of Gastroenterology & Hepatology
|
January 28, 2005
Antiphospholipid syndrome in combination with autoimmune hepatitis
Axel J Hueber, Frank Boxberger, Marion Ganslmayer, et al.
Liver
|
May 25, 2002
Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis
Christoph Herold, Marion Ganslmayer, Christine Deynet, et al.
International Journal of Cancer
|
September 25, 2003
The synthetic retinoid adapalene inhibits proliferation and induces apoptosis in colorectal cancer cells in vitro
Matthias Ocker, Christoph Herold, Marion Ganslmayer, et al.
Anticancer Research
|
December 11, 2012
Antitumoral efficacy of four histone deacetylase inhibitors in hepatoma in vitro and in vivo
Marion Ganslmayer, Peter Konturek, Christoph Herold, et al.
Digestive Diseases and Sciences
|
December 25, 2002
Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis?
Christoph Herold, Sabine Regn, Marion Ganslmayer, et al.
Cancer Letters
|
April 24, 2004
Potentiated anticancer effects on hepatoma cells by the retinoid adapalene
Matthias Ocker, Christoph Herold, Marion Ganslmayer, et al.
Page
of 4
Search research articles
Search
Showing results (1-10 of 34) with videos related to
Sort By:
Page
of 4
World Journal of Gastroenterology
|
October 12, 2011
Combined inhibitors of angiogenesis and histone deacetylase: efficacy in rat hepatoma
Marion Ganslmayer, Annette Zimmermann, Steffen Zopf, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 14, 2025
Sevoflurane-induced periostitis
Christian Beyer, Bernhard Manger, Marion Ganslmayer, et al.
Studies in Health Technology and Informatics
|
May 20, 2008
A randomized controlled trial to evaluate an electronic scoring tool in the ICU
Thomas Bürkle, Alexander Beisig, Marion Ganslmayer, et al.
Scandinavian Journal of Gastroenterology
|
January 2, 2009
Peginterferon alfa-2a relapse rates depend on weight-based ribavirin dosage in HCV-infected patients with genotype 1: results of a retrospective evaluation
Steffen Zopf, Christoph Herold, Eckhart G Hahn, et al.
European Journal of Gastroenterology & Hepatology
|
January 28, 2005
Antiphospholipid syndrome in combination with autoimmune hepatitis
Axel J Hueber, Frank Boxberger, Marion Ganslmayer, et al.
Liver
|
May 25, 2002
Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis
Christoph Herold, Marion Ganslmayer, Christine Deynet, et al.
International Journal of Cancer
|
September 25, 2003
The synthetic retinoid adapalene inhibits proliferation and induces apoptosis in colorectal cancer cells in vitro
Matthias Ocker, Christoph Herold, Marion Ganslmayer, et al.
Anticancer Research
|
December 11, 2012
Antitumoral efficacy of four histone deacetylase inhibitors in hepatoma in vitro and in vivo
Marion Ganslmayer, Peter Konturek, Christoph Herold, et al.
Digestive Diseases and Sciences
|
December 25, 2002
Can quantitative tests of liver function discriminate between different etiologies of liver cirrhosis?
Christoph Herold, Sabine Regn, Marion Ganslmayer, et al.
Cancer Letters
|
April 24, 2004
Potentiated anticancer effects on hepatoma cells by the retinoid adapalene
Matthias Ocker, Christoph Herold, Marion Ganslmayer, et al.
Page
of 4